SIZE XSSIZE SMSIZE MDSIZE LG

BCOP Self Study

NEW in 2020

  • 20 hours of BCOP and ACPE credit
  • 1 year of credit availability
  • 1 combined post assessment (case study and post-test questions)

With releases scheduled for April and September, the 2020 Self-Study modules will feature cutting-edge discoveries from primary oncology literature published within the last two years. Emphasis will be on case-based application of the readings and content outlines. BCOP Self-Study Modules are on-demand and allow you to review and complete at your convenience for up to one year following the release of the education.

Each module will include access to articles, pre-assessment questions, patient cases and the BCOP post-test. You may choose to complete all or select individual modules, receiving BCOP credit for each completed module which achieves a passing score of 75% or above.

Highlights

  • Leading experts from a variety of specialties and settings
  • Therapeutic developments translated into case-based reviews
  • Application of information to practice-based scenarios
  • Credit given per module – choose one or all

2020 Self-Study

Release I (education released April 2020)

  • Module 1 - Updates in the Treatment of Pancreatic Adenocarcinoma – Sarah Timaeus, PharmD BCOP (2.0 BCOP/ACPE)
  • Module 2 - Anti-Coagulation – Whitney Lewis, RPh PharmD BCOP (2.5 BCOP/ACPE)
  • Module 3 - Immune Checkpoint Inhibitors in HIV-Positive Patients with Advanced Cancer – Suwicha (Nan) Limvorasak PharmD BCOP (2.0 BCOP/ACPE)
  • Module 4 - Updates in Non-Malignant Hematology: Focus on Hemophilia A and Thrombotic Thrombocytopenic Purpura (TTP) – Angela German, PharmD BCOP (2.0 BCOP/ACPE)

HOPA Member Price: $165
Non-Member Price: $215

Purchase now


Release II (education released September 2020)

  • Module 5 - Hyperprogression with Immunotherapy – Kirollos Hanna, PharmD BCOP BCPS (1.5 BCOP/ACPE)
  • Module 6 - CINV in Transplantation – Julianne Orr, PharmD BCOP (2.0 BCOP/ACPE)
  • Module 7 - Early Antibiotic De-Escalation – Carissa Treptow, PharmD BCOP (2.0 BCOP/ACPE)
  • Module 8 - NSCLC – Sarah Hayes, PharmD BCOP and Melvin Rivera, PharmD BCOP (3.0 BCOP/ACPE)
  • Module 9 - Gastric and Esophageal Cancers – Matthew Arango, PharmD BCOP (3.0 BCOP/ACPE)

HOPA Member Price: $215
Non-Member Price: $280

Purchase now


2020 Self-Study Bundle – Purchase both modules as a bundle and save. 

HOPA Member Price: $360
Non-Member Price: $480

Purchase now


2020 Self-Study is also a part of the 2020 BCOP Complete Program Bundle. Purchase the suite of all 2020 BCOP education, including BCOP Annual Conference and BCOP Updates Course, and save. 

HOPA Member Price: $700
Non-Member Price: $1030

Purchase now


2019 Self-Study

2019 Self-Study Release I is no longer available. Release II includes 3 modules and offers up to 7.5 BCOP/ACPE credits. It will be available through February 28, 2020

2019 BCOP Self-Study Modules – Release II

HOPA Member Price: $165
Non-Member Price: $225

Purchase now

2019 BCOP Self-Study – Release II is also a part of both the 2019 BCOP Program Bundle and BCOP Self-Study Online Module Bundle. If you've already purchased the 2019 BCOP Program Bundle or BCOP Self-Study Online Module Bundle, you can access your Self-Study Modules in My Education Library.


Accreditation Statement:

logo acpeThe Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. An ACPE statement of credit will be issued only upon completion of the pre/post- assessment and a post-activity evaluation form. ACPE test must be completed by February 28, 2020.

education speaker bpslogo The Hematology/Oncology Pharmacy Association (HOPA) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certification oncology credit (BCOP). A BCOP statement of credit will be issued only upon completion of a post-activity evaluation form and post-test, with a passing grade of 75% achieved. Test must be completed by February 28, 2020.

Disclosure of Conflicts of Interest: The Hematology/Oncology Pharmacy Association (HOPA) assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by HOPA for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. HOPA is committed to providing its learners with high-quality CE activities and related materials that promote improvements of quality in healthcare and not a specific proprietary business interest of a commercial interest.

Reported Areas of Conflict: Hematology/Oncology Pharmacy Association does not view the existence of relationships as an implication of bias or that the value of the material is decreased. The content of the activity was planned to be balanced, objective, and scientifically rigorous. Occasionally, authors may express opinions that represent their own viewpoint. Conclusions drawn by participants should be derived from objective analysis of scientific data. Unlabeled/unapproved uses of drugs. All faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs and devices.

xs
sm
md
lg